Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Maverix MedicalMaverix Medical Announces FDA 510(k) Clearance for the Narwhal™ Cryo SystemConsole-free, single-use cryoprobe brings cryobiopsy to the bronchoscopy suite without dedicated capital equipment — Maverix Medical, a company focused on revolutionizing the diagnosis and treatment of lung cancer, today announced that the U....
- PleoPharma, IncPleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for Cannabis Withdrawal in Patients with Cannabis Use DisorderNIH/NIDA funding will support a pivotal clinical program for an investigational treatment for adults with cannabis use disorder — PleoPharma, Inc., a clinical-stage development company focused on cannabis-related health issues, today...
- Michael J. Epstein of The Epstein Law Firm Selected by Peers for Inclusion in The Best Lawyers in America® 2027New Jersey attorney recognized for expertise in commercial litigation, medical malpractice and personal injury litigation
- Loblaw Companies LimitedShoppers Foundation for Women’s Health™ invests $600K in 15 community partners across CanadaCompanies: Loblaw CompaniesShoppers Foundation for Women’s Health™ is pleased to announce $600,000 in funding this year for 15 community partners delivering local initiatives that help improve health outcomes for women across the country.
- iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual SymposiumPHILADELPHIA, August 20, 2026--iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM
- Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary FibrosisRein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LTI-03 for the treatment of idiopathic pulmonary fibrosis.
- Bayer Summary BayerBayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026Companies: BayerWHIPPANY, N.J., August 20, 2026--Bayer Summary
- Rhelion Life Sciences Corp.Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease Trial DesignCollaboration looks to explore the use of Darmiyan's FDA De Novo authorized BrainSee® imaging platform, authorized for predicting risk of progression to Alzheimer's disease in patients with amnestic mild cognitive impairment, as well as Darmiyan's core technology, the Virtual Microscope, tailored towards use in pharmaceutical clinical trialsThe goal of the collaboration is to inform the identification, selection and monitoring of the best candidates for clinical trials of PEX010, Rhelion's...
- Samsung[Video] [Galaxy Unpacked July 2026] Samsung Health Envisions Simpler, More Connected Care With AICompanies: Samsung ElectronicsManaging health can be complicated. But what if it didn’t have to be? At Galaxy Unpacked July 2026 in London on July 22, Dr. Hon Pak, Senior Vice President and Head of the Digital Health Team, Mobile eXperience (MX) Business at Samsung Electronics, sat down with cognitive neuroscientist and science communicator Dr. Dong-seon Chang to […]
- Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plcFORM 8.5 (EPT/RI)
- Rise Nano Optics Ltd.Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical RelationshipRise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, is pleased to announce that it has joined The Vision Council, one of the optical industry's leading trade associations representing hundreds of eyewear manufacturers, lens laboratories, retailers, distributors and technology companies across North...
- TLC HealthcareTLC Healthcare engages Mayo Clinic Global Consulting to advance healthcare excellenceMELBOURNE, Australia, August 20, 2026--TLC Healthcare (TLC) - a leading healthcare provider of multi-generational healthcare across Victoria, Australia - announced today that it has engaged Mayo Clinic Global Consulting to provide advisory services related to TLC’s integrated care expansion with the launch of its new Hospital Day Surgery in Hallam, Victoria.